îæ€çŽ¢
îæ€çŽ¢
î
Ascentage Pharma Group International
AAPGîãŠã©ãããªã¹ãã«è¿œå
15.580USD
0.0000.00%
ååŒæé 09/16, 15:19ïŒETïŒ
1.45Bæ䟡ç·é¡
0.00çŽè¿12ã¶æPER
Ascentage Pharma Group Internationalã«ã€ã㊠äŒæ¥å
Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.
Ascentage Pharma Group International ãããã£ãŒã«
îäŒæ¥ã³ãŒãAAPG
äŒç€ŸåAscentage Pharma Group International
äžå Žæ¥Oct 28, 2019
æé«çµå¶è²¬ä»»è
ãCEOãYang (Dajun)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Depository Receipt
決ç®ææ«- -
æ¬ç€Ÿæåšå°68 Xinqing Road, Suzhou Industrial Park
éœåžSUZHOU
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœChina
éµäŸ¿çªå·- -
é»è©±çªå·
ãŠã§ããµã€ãhttps://www.ascentage.cn/
äŒæ¥ã³ãŒãAAPG
äžå Žæ¥Oct 28, 2019
æé«çµå¶è²¬ä»»è
ãCEOãYang (Dajun)
Ascentage Pharma Group Internationalã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Dajun Yang, M.D., Ph.D.
Dr. Dajun Yang, M.D., Ph.D.
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Shaomeng Wang, Ph.D.
Dr. Shaomeng Wang, Ph.D.
Non-Executive Director, Co-Founder
Non-Executive Director, Co-Founder
--
--
Mr. Dazhong (Simon) Lu
Mr. Dazhong (Simon) Lu
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Changqing Ye
Mr. Changqing Ye
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Wei Ren
Mr. Wei Ren
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Lead Independent Non-Executive Director
Lead Independent Non-Executive Director
--
--
Dr. Yifan Zhai, M.D., Ph.D.
Dr. Yifan Zhai, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Raymond Jeffrey (Jeff) Kmetz
Mr. Raymond Jeffrey (Jeff) Kmetz
Chief Business Officer
Chief Business Officer
--
--
Mr. Thomas Joseph (Tom) Knapp, J.D.
Mr. Thomas Joseph (Tom) Knapp, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--
Ms. Marina S. Bozilenko
Ms. Marina S. Bozilenko
Independent Non-Executive Director
Independent Non-Executive Director
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Dajun Yang, M.D., Ph.D.
Dr. Dajun Yang, M.D., Ph.D.
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Shaomeng Wang, Ph.D.
Dr. Shaomeng Wang, Ph.D.
Non-Executive Director, Co-Founder
Non-Executive Director, Co-Founder
--
--
Mr. Dazhong (Simon) Lu
Mr. Dazhong (Simon) Lu
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Changqing Ye
Mr. Changqing Ye
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Wei Ren
Mr. Wei Ren
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Lead Independent Non-Executive Director
Lead Independent Non-Executive Director
--
--
ãããã質å
Ascentage Pharma Group Internationalã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îAscentage Pharma Group Internationalã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ããDr. Dajun Yang, M.D., Ph.D.
Ascentage Pharma Group InternationalïŒAAPGïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2026Q1æç¹ã§ãAscentage Pharma Group Internationalã®æ ªåŒãä¿æããŠããæ©é¢ã¯25瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ65.84Kã§ãå
šäœã®0.07%ãå ããŠããŸãã2025Q4ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯-220958.00å¢å ããŠããŸãã